Guidance - Spark Newswire

1 minute read

Biodesix Sees FY23 Revenue Guidance Of $52M-$55M Vs. $52.51M Estimate

Today, 9:34 AM

Guidance represents anticipated 36-44% growth over 2022 total revenue from Lung Diagnostic testing, Biopharmaceutical Services and COVID-19 testing; Excluding 2022 COVID-19 testing

BDSX

1 minute read

Science 37 Sees FY23 Revenue Guidance Of $55M-$60M Vs. $73.66M Estimate

By Benzinga Newsdesk

Today, 9:34 AM

The company expects adjusted EBITDA guidance of $(50.0) million to $(48.0) million.

SNCE

2 minute read

Risk On? Jeremy Siegel Sees S&P 500 Gaining 15% This Year, Here’s Why

By AJ Fabino

Today, 9:34 AM

Wharton Professor Jeremy Siegel suggests that if unemployment rates remain low, earnings figures may be underestimated.

SPY

1 minute read

Bloomberg Reporter Tweets ‘$RIVN Has Told Staff That Production Of 62,000 Units Is Planned For This Year. That’s 12,000 More Than The Guidance Given Earlier This Weak During Earnings’; Shares Move Higher

By Happy Mohamed

Today, 9:34 AM

https://twitter.com/EdLudlow/status/1631735011912347650

RIVN

3 minute read

The AI ‘OG’ Just Blew Out It’s Financial Results — And Shares Are On A Tear

By AJ Fabino

Today, 9:34 AM

The overarching stock story of 2023 — while still early into the year — has been focused on artificial intelligence, namely OpenAI’s sophisticated chatbot ChatGPT.

2 minute read

Why ChargePoint’s Dip Is Your Ticket To Electric Profits: What 2 Analysts Think

By AJ Fabino

Today, 9:34 AM

Shares of ChargePoint Holdings Inc (NYSE: CHPT) fell more than 11% in Friday’s premarket session after the company reported an earnings miss and issued guidance below consensus estimates.

CHPT